PASITHEA THERAPEUTICS CORP. Increase (Decrease) in Other Operating Assets
PASITHEA THERAPEUTICS CORP. (KTTA) reported Increase (Decrease) in Other Operating Assets of -$2.26 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2025-03-24
- PASITHEA THERAPEUTICS CORP. increase (decrease) in other operating assets for the quarter ending 2024-12-31 was $44.61K.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in other operating assets for the quarter ending 2024-09-30 was -$6.32K.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in other operating assets for the quarter ending 2024-06-30 was -$40.49K.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in other operating assets for the quarter ending 2024-03-31 was -$58.00.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in other operating assets for fiscal 2024 was -$2.26K.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in other operating assets for fiscal 2023 was -$158.28K, a 160.19% decline from fiscal 2022.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in other operating assets for fiscal 2022 was $262.99K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $44.61K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $38.29K derived: sum of 2 quarters · filed 2025-03-24 | -$2.20K derived: sum of 3 quarters · filed 2025-03-24 | -$2.26K 10-K · filed 2025-03-24 | |
| 2024-09-30 | -$6.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$46.82K derived: sum of 2 quarters · filed 2024-11-13 | -$46.87K 10-Q · filed 2024-11-13 | -$48.68K derived: sum of 4 quarters · filed 2025-03-24 | |
| 2024-06-30 | -$40.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$40.55K 10-Q · filed 2024-08-13 | -$42.36K derived: sum of 3 quarters · filed 2025-03-24 | -$388.04K derived: sum of 4 quarters · filed 2025-03-24 | |
| 2024-03-31 | -$58.00 10-Q · filed 2024-05-14 | -$1.86K derived: sum of 2 quarters · filed 2025-03-24 | -$347.55K derived: sum of 3 quarters · filed 2025-03-24 | ||
| 2023-12-31 | -$1.80K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$347.49K derived: sum of 2 quarters · filed 2025-03-24 | -$158.28K 10-K · filed 2025-03-24 | ||
| 2023-09-30 | -$345.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$156.48K 10-Q · filed 2024-11-13 | |||
| 2023-06-30 | $189.20K 10-Q · filed 2024-08-13 | ||||
| 2022-12-31 | -$602.99K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $183.40K derived: sum of 2 quarters · filed 2024-03-29 | $262.99K 10-K · filed 2024-03-29 | $725.54K 10-K · filed 2023-03-30 | |
| 2022-09-30 | $786.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $865.99K 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $79.59K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |